Technical Support
(877) SEPAX-US
, press 3
TechSupport@sepax-tech.com
Contact Us
|
Sign In
|
Home
About Sepax
Company Profile
Technology
Employment
Contact Us
Products
By Separation Mode
By Brand
By Sample Based Application
Size Exclusion
Ion Exchange
Hydrophobic Interaction
Ion Exclusion
Sub-2 UHPLC
Purification
Reversed Phase
Mixed-mode Phase
HILIC
View All
SEC-MALS
Unix
/
Unix-C
Zenix
/
Zenix-C
SRT
/
SRT-C
SRT-10 / SRT-10C
Proteomix HIC
/
IEX
Antibodix
Carbomix
Proteomix RP
View All
ADC
Antibody
Biosimilar
Carbohydrate
Cell Lysate
DNA/RNA
Fusion Protein
Glycan
Glycoprotein
Heparin
Insulin
Membrane Protein
Organic Acid
PEG/PEGylated Protein
Peptide
Polymer
Protein
Vaccine/VLP
Others
Services
Analytical Chrom.
Prep Purification
Custom Resin
Surface Coating
Affinity Services
Application
Resources
Order
How May We Help You?
X
Submit
How May We Help You?
X
Name
Email
Phone
How May We Help You?
X
Your question has been submitted.
We will respond back to you shortly.
Ask Another
How May We Help You?
X
Please fill out all required fields.
Try Again
Representative Literature References
Click a row to open its literature reference.
Product
';
All
Bio-C4
Bio-C8
BioMix SEC-300
BR-C18
Carbomix H-NP10
GP-C18
GP-C8
HP-Diol
Nanofilm SEC-150
Nanofilm SEC-250
Nanofilm SEC-500
Polar MC-SP, 30 μm
Polar-Imidazole
Proteomix HIC butyl-NP5
Proteomix HIC Ethyl NP5
Proteomix RP-1000
Proteomix SAX NP3
Proteomix SAX-NP (4.6 mm × 150 mm, 5 μm; Sepax)
Proteomix SAX-NP3
Proteomix SAX-NP5
Proteomix SCX NP5
Proteomix SCX-NP10, Antibodix WCX-NP5
Proteomix SCX-NP5
Proteomix SCX-NP5, PEEK
SEC
SRT 2000 4.6X30
SRT SEC 300, 500, and 1000
SRT SEC-100
SRT SEC-1000
SRT SEC-1000 PEEK
SRT SEC-150
SRT SEC-2000
SRT SEC-300
SRT SEC-300, SRT SEC-500, SRT SEC-1000
SRT SEC-500
SRT-10 300
SRT-10 SEC-300
SRT-1000
SRT-10C SEC-100
SRT-10C SEC-300
SRT-150
SRT-2000
SRT-C SEC-1000
SRT-C SEC-1000, SRT-C SEC-2000
SRT-C SEC-150
SRT-C SEC-300
SRT-C SEC-500
Unix-C SEC-300
Zenix 300
Zenix SEC 300
Zenix SEC-100
Zenix SEC-150
Zenix SEC-300
Zenix SEC-300 & Proteomix HIC butyl-NP5
Zenix SEC-300, 3um, 300 A 7.8 x 300 mm
Zenix SEC-300, 4.6 x 300mm
Zenix SEC-80
Zenix-C
Zenix-C and Proteomix HIC butyl-NP5
Zenix-C SEC-150
Zenix-C SEC-300
Zenix-C SEC-80
PN
';
All
101185-4615
102185-4625
110043-4625, 110043-10025
213300-4615
213300-4630
213300-4630, 431NP5-4603
213300-7830
213300LS-7830
214300-7830
215150
215150-7825
215150-7830
215300-4625
215300-7815
215300-7815, 215500-7815, 215950-7815
215300-7830
215500-4630
215500-7830, 215500-7805, 215300-7830, 215300-7805, 215950-7830, 215950-7805
215950-30030
215950-4630
215950-7830
215950-7830, 102002-COUPLER, 215950-7805
215950P-4630
215980-10030
215980P-4630
225300-21230
225300-21230, 225300-10030
231300-4615
233150-7830
233300-10030
233300-4630
233300-7830
233300-7830 & 431NP5-4603
235150
235300-4625
235300-4630
235300-7830
235500-21230
235500-4615, 102002-COUPLER, 235500-4605
235980-7830,102002-COUPLER, 235950-7830
235980-7830; 235950-7830
239100-10030
239300-21230
239300-30030
283030
401NP10-4625, 401NP10-10025, 401NP10-21225, 401NP10-10005, 602NP5-4625
401NP5-4610
401NP5P-4625
403NP3-7815
403NP5-4615
403NP5-4625
431NP5-4603
431NP5-4605
432NP5-7810
465950-2105
465950-2110
465950-2115
465950-4610
465950-4615
N/A
Not Mentioned
Separation Mode
';
All
HIC
IEX
RP
SEC
OTHER
Broad Sample Type
';
All
2-AA Labeled Glycan Standards, Others
AAV
ADC
ADC, Fusion Protein
Antibody
Antibody, IgE
Bispecific Antibody
BsAbs
BsMAb
Carbohydrate
Cell Lysate
Dendritic Polymer, Polymeric Nanomedicines
DNA
DNA/RNA
DNA/RNA/OLIGO
Enzymes
Factor VIII Fc Fusion Protein
Fusion Protein
GPCR, Membrane Protein
Insulin
Liposome
Membrane Protein
Membrane Protein, Rhodopsin
Oligodeoxynucleotides
Oligonucleotides
Other Proteins
Others
Others, Protein
Others-nanotube
PEG/PEGylated Protein
Peptide
Polymer
Polymer of Cefmetazole
Polymeric Amines and Ampholytes
Polymeric Substances
Polyurethane/Epoxy Hybrid Polymers
Protein
Protein, DNA/RNA
Protein-Kinase
Protein-Peptide Complex
Saccharides
Small Molecule
Urine
Vaccine
VLP/Virus/Vaccine
Wastewater
Specific Sample
';
All
(His)-tagged hFZD7 CRD
5.8S and 5S rRNA
AA and EGF
AAV
AAV8 and AAV9
AAV9
AAV9, AAV2
ABF710
ACKR3
ADC
ALK1-Fc fusion protein
ant-TNF-ang2 bsMab
anthrax vaccines pp-dPA83
Anti-HER2 Immune-Stimulating ADC
Anti-tumor necrosis factor (TNF), IL-17A, BsMAb
Antibody
antisense oligonucleotide (ASO)
BcRsaM protein
bispecific antibody
BsAbs
BsMAb
BsMAb, IgG1, knob-into-hole
CAS-9
Cas-9 and gRNA
CdiIo2 MC58-1, an orphan CDI immunity protein from N. meningitidis MC58.
Cetuximab
chemokine receptor (45kd), viral chemokine, disulfide trapped complexes (55kd), N terminal-Cys CXCR4-Cys: Chemokine Receptor vMIP-II-Cys: viral chemokine
Chemokine, Herpesviridae (herpesvirus), 7TM receptor, Baculovirus infected Spodoptera frugiperda (Sf9) insect cells
chemokines, CXCL12, G protein
circ-arRNA
circRNA
circular mRNA
Clarified cell culture supernatant
CPf1 and CAS-9 analogs
CRISPR-Cpf1 (Cas12a)
cRNA - Engineered
Cysteine ADC based on IgG1
cytokinin-activating BP1253
desialylated protein
Factor VIII Fc Fusion protein
FcgRIIA and FcgRIIB
FcγR
Generalized Modules for Membrane Antigens (GMMA), which are are outer membrane vesicles naturally released by Gram-negative bacteria. GMMA are small outer membrane vesicles-like blebs (40-200 nm diameter) spontaneously released by Gram-negative bacteria ...
Glycan-based Site Specific ADC
GPCR
HBcAg
hepatitis B core antigen (HBcAg) VLP as carrier for therapeutic human papillomavirus (HPV) vaccines, expressed efficiently in E. coli cells, recombinant vaccine protein HBcAg-E749–57 was assembled into VLPs similar to the carrier protein HBcAg, whic…
Hepatitis B Virus
HEX Antibody carrier or HEX-antibody complexes
HIV Env Trimer
HIV Trimer
HIV-1 Env Antibody
HPV16 E7-specific vaccine
Human diacylglycerol O-acyltransferase-1 (hDGAT1), from cell memebranes.
Human IgG1 Mab
Human interleukin 11α receptor
IgG
IgG2 isoforms
IgG4
infliximab
influenza vaccine candidate H1ssF
Insulin Analogs
IP268 and Dulaglutide (IP118)
α4β2–Fab complexes
lentil legumin-like protein
Lysozyme-like Protein, STM3605 protein
mAb
mAbs
mAbs - SARS-CoV-2
mAbs of 12 varieties
mAbs with Vκ or Vλ variability
Membrane Protein
methylated peptides
MMAE-trastuzumab ADC
mRNA-LNP (Lipid Nanoparticle)
N/A
native IgG1 and pI engineered
Oligosaccharides
OmpA C-terminal domains
Oxy Enzymes
p-rhASM/G-S
paclitaxel (PTX)
partial heavy chain/light chain assemblies of various regions to create chimeric antibodies.
Pegunigalsidase
PEGylated Lipsome Peptide
Pfs25-CP VLP
Pfs25-CP VLP.
Polymerase
Polysaccharide Vaccine
Protein
protein and small molecules
protein candidate vaccine
protein-metabolite complexes
Protein-peptide complex
Recombinant T cell receptors (TCR)/TCR fragments
rFVIII
RNA
SARS-COV-2 Spike Protein
scFv-IgG bispecific
sdAbs
SEC c2G4-BDS; CMB-BDS-1410-001
Sildenafil and Carbamazepine
Site Specific ADC
Site-specific ADC
STS-1 enzyme
Synthetic nanobodies
Thienoduocarmycin-trastuzumab ADC
Trastuzumab-derived variants containing pAMF were conjugated to MMAF, MMAE, and maytansinoid
vaccine protein
Various VAR2CSA domains
VLP
xenopolymerase for RT-PCR
1
2
Next
View All
Year
Product
PN
Sep. Mode
Broad Sample Category
Specific Sample
Title
2023
Proteomix HIC Butyl-NP5
431NP5-4603
HIC
ADC
Thienoduocarmycin-trastuzumab ADC
Novel Thienoduocarmycin-trastuzumab ADC Demonstrates Strong Anti-tumor Efficacy
Proteomix HIC Butyl-NP5
431NP5-4603
ADC
Thienoduocarmycin-trastuzumab ADC
2023
Zenix-C SEC-300
233300-7830
SEC
ADC
Glycan-based Site Specific ADC
Hiding Payload Inside the IgG Fc Cavity Significantly Enhances the Therapeutic Index of Antibody Drug Conjugates
Zenix-C SEC-300
233300-7830
ADC
Glycan-based Site Specific ADC
2022
Proteomix RP-1000
465950-2110
RP
ADC
Anti-HER2 Immune-Stimulating ADC
Design and Characterization of Immune-Stimulating Imidazo[4,5-c]quinoline Antibody-Drug Conjugates
Proteomix RP-1000
465950-2110
ADC
Anti-HER2 Immune-Stimulating ADC
2021
Proteomix RP-1000
465950-2105
RP
ADC
Cysteine ADC based on IgG1
In-situ Reverse Phased HPLC Analysis of Intact Antibody-Drug Conjugates
Proteomix RP-1000
465950-2105
ADC
Cysteine ADC based on IgG1
2021
Zenix-C
233300-4630
SEC
ADC
sdAbs
Single Domain Antibodies as Carriers for Intracellular Drug Delivery: A Proof of Principle Study
Biomolecules 2021, 11(7), 927; https://doi.org/10.3390/biom11070927
Zenix-C
233300-4630
ADC
sdAbs
2019
Proteomix HIC Butyl-NP5
431NP5-4605
HIC
ADC
MMAE-trastuzumab ADC
Homogeneous antibody-drug conjugates: DAR 2 anti-HER2 obtained by conjugation on isolated light chain followed by mAb assembly
Proteomix HIC Butyl-NP5
431NP5-4605
ADC
MMAE-trastuzumab ADC
2019
Proteomix HIC Butyl-NP5
431NP5-4603
HIC
ADC
Site-specific ADC
Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engin eered antibody and a dual-maleimide pyrrolobenzodiazepine dimer
Proteomix HIC Butyl-NP5
431NP5-4603
ADC
Site-specific ADC
2019
Proteomix HIC Ethyl NP5
432NP5-7810
HIC
ADC
ADC
Site-Specific Conjugation of the Indolinobenzodiazepine DGN549 to Antibodies Affords Antibody–Drug Conjugates with an Improved Therapeutic Index as Compared with Lysine Conjugation
Bioconjugate Chemistry 31.1 (2019): 93-103.
Proteomix HIC Ethyl NP5
432NP5-7810
ADC
ADC
2019
Proteomix RP-1000
465950-4610
RP
ADC
ADC
Efficient Production of Homogeneous Lysine-Based Antibody Conjugates Using Microbial Transglutaminase
Bioconjugation. Humana, New York, NY, 2019. 53-65.
Proteomix RP-1000
465950-4610
ADC
ADC
2017
Proteomix RP-1000
N/A
RP
ADC
Site Specific ADC
Site-Specific Conjugation to Native and Engineered Lysines in Human Immunoglobulins by Microbial Transglutaminase
Bioconjugate Chemistry 2017 28 (9), 2471-2484 DOI: 10.1021/acs.bioconjchem.7b00439
Proteomix RP-1000
N/A
ADC
Site Specific ADC
1
2
Next
View All
© 2024 Sepax Technologies, Inc. All Rights Reserved.
Products
|
Privacy Policy
|
Career
|
Contact Us
